Skip to main navigation Skip to search Skip to main content

Pharmacological interventions for chronic pain in children: an overview of systematic reviews

  • Christopher Eccleston
  • , Emma Fisher
  • , Tess E. Cooper
  • , Marie Claude Grégoire
  • , Lauren C. Heathcote
  • , Elliot Krane
  • , Susan M. Lord
  • , Navil F. Sethna
  • , Anna Karenia Anderson
  • , Brian Anderson
  • , Jacqueline Clinch
  • , Andrew L. Gray
  • , Jeffrey I. Gold
  • , Richard F. Howard
  • , Gustaf Ljungman
  • , R. Andrew Moore
  • , Neil Schechter
  • , Philip J. Wiffen
  • , Nick M.R. Wilkinson
  • , David G. Williams
  • Chantal Wood, Miranda A.L. van Tilburg, Boris Zernikow
  • Ghent University
  • University of Oxford
  • University of Sydney
  • Dalhousie University
  • Stanford University
  • John Hunter Children's Hospital
  • The University of Newcastle, Australia
  • Boston Children’s Hospital
  • Royal Marsden Hospital, London
  • Auckland University of Technology
  • University of Bristol
  • Royal National Hospital for Rheumatic Diseases
  • University of KwaZulu-Natal
  • University of Southern California
  • Children's Hospital Los Angeles
  • Uppsala University
  • University Hospital of Limoges
  • Campbell University
  • University of North Carolina
  • Children's and Adolescent's Hospital
  • Witten/Herdecke University
  • Great Ormond St Hospital NHS Foundation Trust
  • King's College London
  • University College London

Research output: Contribution to journalArticlepeer-review

88   Link opens in a new tab Citations (SciVal)
557 Downloads (Pure)

Abstract

We know little about the safety or efficacy of pharmacological medicines for children and adolescents with chronic pain, despite their common use. Our aim was to conduct an overview review of systematic reviews of pharmacological interventions that purport to reduce pain in children with chronic noncancer pain (CNCP) or chronic cancer-related pain (CCRP). We searched the Cochrane Database of Systematic Reviews, Medline, EMBASE, and DARE for systematic reviews from inception to March 2018. We conducted reference and citation searches of included reviews. We included children (0-18 years of age) with CNCP or CCRP. We extracted the review characteristics and primary outcomes of ≥30% participant-reported pain relief and patient global impression of change. We sifted 704 abstracts and included 23 systematic reviews investigating children with CNCP or CCRP. Seven of those 23 reviews included 6 trials that involved children with CNCP. There were no randomised controlled trials in reviews relating to reducing pain in CCRP. We were unable to combine data in a meta-analysis. Overall, the quality of evidence was very low, and we have very little confidence in the effect estimates. The state of evidence of randomized controlled trials in this field is poor; we have no evidence from randomised controlled trials for pharmacological interventions in children with cancer-related pain, yet cannot deny individual children access to potential pain relief. Prospero ID: CRD42018086900.

Original languageEnglish
Pages (from-to)1698-1707
Number of pages10
JournalPain
Volume160
Issue number8
DOIs
Publication statusPublished - 1 Aug 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Fingerprint

Dive into the research topics of 'Pharmacological interventions for chronic pain in children: an overview of systematic reviews'. Together they form a unique fingerprint.

Cite this